LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
6.81
+0.02 (0.29%)
Jun 10, 2026, 12:42 PM EDT - Market open
LENZ Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, LENZ Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $32. The average 1-year stock price forecast is 369.90% higher than the current stock price, while the lowest is $12 (+76.21%) and the highest is $60 (+781.06%).
Price Target: $32 (+369.90%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Reiterates $26 → $20 | Buy | Reiterates | $26 → $20 | +193.69% | May 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $29 → $31 | Buy | Maintains | $29 → $31 | +355.21% | May 12, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $48 → $38 | Buy | Reiterates | $48 → $38 | +458.00% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Hold Downgrades $39 → $12 | Hold | Downgrades | $39 → $12 | +76.21% | May 12, 2026 |
Financial Forecast
Revenue This Year
19.04M
from 19.09M
Decreased by -0.25%
Revenue Next Year
64.52M
from 19.04M
Increased by 238.87%
EPS This Year
-4.56
from -2.85
EPS Next Year
-3.47
from -4.56
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 24.8M | ||
| Avg | 19.0M | ||
| Low | 12.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.2% | ||
| Avg | -0.3% | ||
| Low | -32.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -4.56 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |